Chang Emily J, Zangwill Kenneth M, Lee Hang, Ward Joel I
UCLA Center for Vaccine Research, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Pediatr Infect Dis J. 2002 Feb;21(2):97-102. doi: 10.1097/00006454-200202000-00003.
Withdrawal of the tetravalent rhesus-human rotavirus vaccine Rotashield because of its association with intussusception raised concerns about a potential link between natural rotavirus disease and intussusception. Our objective was to determine whether such an association exists.
In the Southern California Kaiser Permanente Health Care Plan, a large health maintenance organization, from October, 1992, to July, 1999, we retrospectively identified by computerized data and medical charts all children <3 years old with intussusception, and from 1997 to 1999 we independently identified by prospective clinical and laboratory evaluation children <3 years old with rotavirus diarrhea. We compared the epidemiologic characteristics of intussusception and rotavirus infection in our study population and evaluated for the presence of both diseases in individual patients.
Using computerized data we identified 124 cases of intussusception, 101 (81%) of which were confirmed by medical chart and radiologic reviews. The incidences for infants <1 year old and for children <3 years old were 41 (95% confidence interval, 32 to 55) and 17 (95% confidence interval, 13 to 20) per 100,000 child years, respectively. Between November 1997 and July 1999, we identified 470 cases of rotavirus diarrhea and none had intussusception. Although rotavirus diarrhea had a distinct peak incidence between December and February, intussusception had no apparent seasonality. The age distributions overlapped, but intussusception occurred at an earlier age than rotavirus disease.
We found no epidemiologic evidence for an association between intussusception and natural rotavirus infection, but our study was limited by an insufficient number of cases to definitively exclude a causal link. The dramatic winter peak of rotavirus disease had no discernable parallel in the incidence of intussusception. Our data suggest that the association between tetravalent rhesus-human rotavirus vaccine and intussusception may possibly result from the nonhuman rotavirus components of that vaccine.
四价恒河猴 - 人轮状病毒疫苗Rotashield因与肠套叠有关而被撤市,这引发了人们对自然轮状病毒疾病与肠套叠之间潜在联系的担忧。我们的目的是确定是否存在这种关联。
在南加州永久医疗保健计划(一个大型健康维护组织)中,从1992年10月至1999年7月,我们通过计算机化数据和病历回顾性地识别了所有3岁以下患有肠套叠的儿童,并且从1997年至1999年,我们通过前瞻性临床和实验室评估独立识别了3岁以下患有轮状病毒腹泻的儿童。我们比较了研究人群中肠套叠和轮状病毒感染的流行病学特征,并评估了个体患者中两种疾病的共存情况。
利用计算机化数据,我们识别出124例肠套叠病例,其中101例(81%)经病历和放射学检查确诊。1岁以下婴儿和3岁以下儿童的发病率分别为每10万个儿童年41例(95%置信区间,32至55)和17例(95%置信区间,13至20)。在1997年11月至1999年7月期间,我们识别出470例轮状病毒腹泻病例,无一例发生肠套叠。虽然轮状病毒腹泻在12月至2月间有明显的发病高峰,但肠套叠没有明显的季节性。年龄分布有重叠,但肠套叠发病年龄早于轮状病毒疾病。
我们没有发现肠套叠与自然轮状病毒感染之间存在关联的流行病学证据,但我们的研究因病例数量不足而受到限制,无法明确排除因果关系。轮状病毒疾病冬季的显著发病高峰在肠套叠发病率中没有明显的对应情况。我们的数据表明,四价恒河猴 - 人轮状病毒疫苗与肠套叠之间的关联可能是由该疫苗的非人轮状病毒成分导致的。